4.0
19 June 2024
Current employee
Washington, DC
Recommend
CEO approval
Business outlook
Pros
Good purpose and values. A strong, well-known institution in the field of Randomized Controlled Trials.
Cons
Lack of work/life balance at times.
Check out your Company Bowl for anonymous work chats.